BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25677303)

  • 1. A new sequencing approach for N-unsubstituted heparin/heparan sulfate oligosaccharides.
    Liang QT; Xiao XM; Lin JH; Wei Z
    Glycobiology; 2015 Jul; 25(7):714-25. PubMed ID: 25677303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of heparin hexasaccharide library with N-unsubstituted glucosamine residues.
    Liang QT; Du JY; Fu Q; Lin JH; Wei Z
    Glycoconj J; 2015 Nov; 32(8):643-53. PubMed ID: 26275985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of heparin/heparan sulfate oligosaccharides with internal N-unsubstituted glucosamine residues for functional studies.
    Wei Z; Deakin JA; Blaum BS; Uhrín D; Gallagher JT; Lyon M
    Glycoconj J; 2011 Dec; 28(8-9):525-35. PubMed ID: 21948150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion-pairing liquid chromatography with on-line electrospray ion trap mass spectrometry for the structural analysis of N-unsubstituted heparin/heparan sulfate.
    Du JY; Chen LR; Liu S; Lin JH; Liang QT; Lyon M; Wei Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():71-76. PubMed ID: 27322632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An approach for separation and complete structural sequencing of heparin/heparan sulfate-like oligosaccharides.
    Huang R; Liu J; Sharp JS
    Anal Chem; 2013 Jun; 85(12):5787-95. PubMed ID: 23659663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of partial de-O-sulfation of heparin oligosaccharide library.
    Lin J; Zheng L; Liang Q; Jiang L; Wei Z
    Carbohydr Res; 2021 Jan; 499():108226. PubMed ID: 33401230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Location of N-unsubstituted glucosamine residues in heparan sulfate.
    Westling C; Lindahl U
    J Biol Chem; 2002 Dec; 277(51):49247-55. PubMed ID: 12374790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved de novo sequencing of heparin/heparan sulfate oligosaccharides by propionylation of sites of sulfation.
    Liang Q; Chopra P; Boons GJ; Sharp JS
    Carbohydr Res; 2018 Jul; 465():16-21. PubMed ID: 29920400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [(1)H,(15)N] HSQC NMR.
    Beecher CN; Manighalam MS; Nwachuku AF; Larive CK
    Anal Bioanal Chem; 2016 Feb; 408(6):1545-55. PubMed ID: 26758598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative susceptibilities of the glucosamine-glucuronic acid and N-acetylglucosamine-glucuronic acid linkages to heparin lyase III.
    Chai W; Leteux C; Westling C; Lindahl U; Feizi T
    Biochemistry; 2004 Jul; 43(26):8590-9. PubMed ID: 15222770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Heparan sulfate/heparin from Colla corii asini by liquid chromatography-electrospray ion trap mass spectrometry.
    Du J; Liu S; Liang Q; Lin J; Jiang L; Chen F; Wei Z
    Glycoconj J; 2019 Jun; 36(3):211-218. PubMed ID: 31016560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of oligosaccharides derived from heparin by ion-pair reversed-phase chromatography/mass spectrometry.
    Doneanu CE; Chen W; Gebler JC
    Anal Chem; 2009 May; 81(9):3485-99. PubMed ID: 19344114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospray ionization time-of-flight mass spectrometry.
    Kuberan B; Lech M; Zhang L; Wu ZL; Beeler DL; Rosenberg RD
    J Am Chem Soc; 2002 Jul; 124(29):8707-18. PubMed ID: 12121115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De Novo Sequencing of Complex Mixtures of Heparan Sulfate Oligosaccharides.
    Huang R; Zong C; Venot A; Chiu Y; Zhou D; Boons GJ; Sharp JS
    Anal Chem; 2016 May; 88(10):5299-307. PubMed ID: 27087275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence analysis of heparan sulphate and heparin oligosaccharides.
    Vivès RR; Pye DA; Salmivirta M; Hopwood JJ; Lindahl U; Gallagher JT
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):767-73. PubMed ID: 10215618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
    Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
    Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophoretic sequencing of heparin/heparan sulfate oligosaccharides using a highly sensitive fluorescent end label.
    Drummond KJ; Yates EA; Turnbull JE
    Proteomics; 2001 Feb; 1(2):304-10. PubMed ID: 11680877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and low molecular weight-heparins disaccharides and oligosaccharides.
    Galeotti F; Volpi N
    J Chromatogr A; 2013 Apr; 1284():141-7. PubMed ID: 23453462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-like heparan sulfate from rabbit cartilage.
    Parra A; Veraldi N; Locatelli M; Fini M; Martini L; Torri G; Sangiorgi L; Bisio A
    Glycobiology; 2012 Feb; 22(2):248-57. PubMed ID: 21933839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequencing Heparan Sulfate Using HILIC LC-NETD-MS/MS.
    Wu J; Wei J; Chopra P; Boons GJ; Lin C; Zaia J
    Anal Chem; 2019 Sep; 91(18):11738-11746. PubMed ID: 31423779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.